U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826950) titled 'Impact of Pharmacy Services on Gynaecology Chemotherapy Safety' on Feb. 10.
Brief Summary: What was studied? We wanted to see whether having pharmacists closely involved in cancer care improves medication safety and reduces severe side effects for patients with gynecologic cancers (like ovarian or uterine cancer) during chemotherapy.
How was the study done?
Who participated? Patients receiving chemotherapy at Peking University First Hospital's Gynecologic Oncology Ward (September 2022-September 2024).
Two groups compared:
Standard care group: Pharmacists provided routine pharmaceutical services.
Full pharmacy care group: Pharma...